Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-08

Clinical Trial Update: Hepcidin Levels in Sickle Cell Disease (SCD)

View source ↗

Summary

The clinical trial examining hepcidin levels in sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kenneth Ataga, MD | Conditions: Sickle Cell Anemia, Sickle - Beta Thalassemia | Status: COMPLETED